JACS
NYSE · N/A
Jackson Acquisition Co-Cl A
$10.48
+0.00 (+0.00%)
Open$10.52
Previous Close$10.48
Day High$10.52
Day Low$10.48
52W High$27.58
52W Low$16.63
Volume—
Avg Volume224.6K
Market Cap281.67M
P/E Ratio—
EPS$0.11
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.70M | 9.17M | 10.79M |
| Net Income | 1.60M | 1.49M | 1.93M |
| Profit Margin | 16.5% | 16.3% | 17.9% |
| EBITDA | 3.23M | 2.99M | 3.58M |
| Free Cash Flow | 1.53M | 1.89M | 1.86M |
| Rev Growth | +20.0% | +20.7% | -1.4% |
| Debt/Equity | 0.53 | 0.48 | 0.63 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |